Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
30.87
-0.18 (-0.58%)
At close: Dec 5, 2025, 4:00 PM EST
31.04
+0.17 (0.55%)
After-hours: Dec 5, 2025, 5:13 PM EST
Stoke Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,763 | 584 | 235 | 364 | 883 | 2,244 | |
| Market Cap Growth | 186.73% | 148.73% | -35.46% | -58.77% | -60.67% | 142.11% | |
| Enterprise Value | 1,439 | 320 | 23 | 118 | 652 | 2,054 | |
| Last Close Price | 30.87 | 11.03 | 5.26 | 9.23 | 23.99 | 61.93 | |
| PS Ratio | 8.70 | 15.98 | 26.75 | 29.34 | - | - | |
| PB Ratio | 5.52 | 2.55 | 1.47 | 1.97 | 4.05 | 7.84 | |
| P/TBV Ratio | 5.72 | 2.55 | 1.47 | 1.97 | 4.05 | 7.84 | |
| EV/Sales Ratio | 7.00 | 8.76 | 2.67 | 9.51 | - | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | 0.00 | |
| Asset Turnover | 0.63 | 0.15 | 0.04 | 0.05 | - | - | |
| Quick Ratio | 6.21 | 5.43 | 6.54 | 7.33 | 12.83 | 25.15 | |
| Current Ratio | 6.53 | 5.81 | 6.99 | 7.77 | 13.37 | 25.73 | |
| Return on Equity (ROE) | 15.02% | -45.80% | -60.80% | -50.20% | -34.06% | -20.47% | |
| Return on Assets (ROA) | 5.20% | -25.35% | -29.62% | -26.36% | -20.04% | -12.59% | |
| Return on Capital (ROIC) | 6.18% | -31.66% | -40.26% | -31.61% | -21.09% | -12.96% | |
| Return on Capital Employed (ROCE) | 8.50% | -43.80% | -58.10% | -46.40% | -38.80% | -18.50% | |
| Earnings Yield | 2.30% | -15.23% | -44.58% | -27.77% | -9.72% | -2.33% | |
| FCF Yield | 2.97% | -14.90% | -35.20% | -9.84% | -7.72% | -1.93% | |
| Buyback Yield / Dilution | -16.83% | -22.76% | -13.11% | -5.87% | -9.71% | -86.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.